戻る Agenda
[V1-S2] Recent Trend of Pharmaceutical Regulation in the World
Session Chair(s)
Guido Rasi, MD
Chairman,Clinical Trial Center of Gemelli Polyclinic Inst; Prof of Microbiology
Tor Vergata University of Rome, Italy
Jens Piero Quartarolo, MD, MBA, MSc
Director of Division for Pharmacovigilance & Medical Devices
Danish Medicines Agency, Denmark
To respond to issues such as innovative technologies, globalization, and the increased awareness about drug safety among the general public, regulators around the world are introducing or revising existing regulation/legislations. In this session, executives from leading regulatory agencies will introduce the latest regulatory trends, as well as cooperation among agencies (e.g. ICH) and other topics.
Speaker(s)
Recent Trend of Pharmaceutical Regulation in Europe
Agnès Saint-Raymond, DrMed
European Medicines Agency, Netherlands
Head of Division International Affairs
Recent Trend of Pharmaceutical Regulation in Americas
Rong Sun, PhD
Health Canada, Canada
Associate Director with the Centre for Evaluation of Radiopharmaceuticals and Bi
Recent Trend of Pharmaceutical Regulation in Asia
Junko Sato, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director
Recent Trend of Pharmaceutical Regulation in Oseania
Alison Cossar
Medsafe, Ministry of Health, NZ, New Zealand
Manager, Product Regulation Branch
John Graham, PhD, MBA
FDA, United States
Director, Office of Research Center for Veterinary Medicine
Rita Purcell, LLM
Health Products Regulatory Authority (HPRA), Ireland
Deputy Chief Executive